Cresco Labs Inc. (CRLBF)

Market Cap	348.42M
Revenue (ttm)	726.35M
Net Income (ttm)	-67.43M
Shares Out	n/a
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,063
Average Volume	500,713
Open	0.930
Previous Close	0.930
Day's Range	0.930 - 0.980
52-Week Range	0.781 - 2.650
Beta	1.99
RSI	56.01
Earnings Date	Mar 14, 2025

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,760
• Stock Exchange: OTCMKTS
• Ticker Symbol: CRLBF

Financial Performance

In 2023, Cresco Labs's revenue was $756.06 million, a decrease of -8.35% compared to the previous year's $824.93 million. Losses were -$175.52 million, -17.22% less than in 2022.